why I bought my bit of PRA6 Jan 2010 17:04
The CEO, Nick Harding, started this journey once before as CEO of Talarius plc. From June
05 to Jan 07 he grew Talarius to become the largest UK AGC operator (200 sites), taking the
share price from 80p to 280p in the process. His plans for Talarius were cut short – in a nice
way – by an earlier than expected, acceptable offer to sell to an Australian based trade buyer
on a 9x multiple.
The expectation was that Talarius, under its new ownership, would continue with its
acquisition plans but, due to problems in its home market, it hasn’t. Nick’s no compete clause
expired and he began the same journey again with Praesepe. This time he and his main
backers are more determined to reach the £100m EBITDA target and an early buy out offer
is, therefore, less likely to be accepted.
Praesepe is at the early stage of its journey. At the time of writing it has 54 sites across the
UK, EBITDA for the 6 months to July 09 of £1.14m, a strong deal pipeline and a market
capitalisation of £17.8m.
The main shareholder (38.5%) is Marwyn – a big backer (and beneficiary) of Talarius
previously. It is committed to the plan and is unlikely to sell out before the target exit.
Depending on the size of the business being bought, Praesepe has acquired sites / groups of
sites on EBITDA multiples up to 7x, with the average around 5.2x. Nick Harding is President
of BACTA (the AGC trade body) and is well thought of in the industry across Europe – this
makes doing deals that bit easier.
On acquisition, sites are usually rebranded (Cashino), refitted with new machines on a
revenue share model with leading manufacturers (uniquely for the industry – lower capex
requirements / no ‘failed’ machines) and the operations are sharpened across the board.
Based on The Crystal Room (so far the flagship Praesepe site in Leicester Square, London),
such actions have a dramatic impact on revenue and earnings: The Crystal Room weekly
revenue is considerably up versus the weeks before the acquisition was completed.
Acquisitions will be funded by a mix of new equity and debt. Currently there are 220m shares
in issue, with 400m authorised. Have in mind that there is the potential for dilution unless
further investments are made as new shares are issued.
If the business sells for £800m with 400m shares issued, that is £2 a share. Compare that to
the 8.5p market price today and, if you believe that the AGC market will follow the rule of
consolidation and that Nick Harding can repeat and build on his previous success at Talarius,
then it is worth a look.